Cargando…

Alzheimer therapy with an antibody against N-terminal Abeta 4-X and pyroglutamate Abeta 3-X

Full-length Aβ1-42 and Aβ1-40, N-truncated pyroglutamate Aβ3-42 and Aβ4-42 are major variants in the Alzheimer brain. Aβ4-42 has not been considered as a therapeutic target yet. We demonstrate that the antibody NT4X and its Fab fragment reacting with both the free N-terminus of Aβ4-x and pyroglutama...

Descripción completa

Detalles Bibliográficos
Autores principales:	Antonios, Gregory, Borgers, Henning, Richard, Bernhard C., Brauß, Andreas, Meißner, Julius, Weggen, Sascha, Pena, Vladimir, Pillot, Thierry, Davies, Sarah L., Bakrania, Preeti, Matthews, David, Brownlees, Janet, Bouter, Yvonne, Bayer, Thomas A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4667289/ https://www.ncbi.nlm.nih.gov/pubmed/26626428 http://dx.doi.org/10.1038/srep17338

Ejemplares similares

Intraneuronal pyroglutamate-Abeta 3–42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model
por: Wirths, Oliver, et al.
Publicado: (2009)

Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer’s disease cases
por: Wirths, Oliver, et al.
Publicado: (2009)

N-truncated Abeta starting with position four: early intraneuronal accumulation and rescue of toxicity using NT4X-167, a novel monoclonal antibody
por: Antonios, Gregory, et al.
Publicado: (2013)

Synaptic Alterations in Mouse Models for Alzheimer Disease—A Special Focus on N-Truncated Abeta 4-42
por: Dietrich, Katharina, et al.
Publicado: (2018)

Is abeta a sufficient biomarker for monitoring anti-abeta clinical studies? A critical review
por: Moreth, Jens, et al.
Publicado: (2013)

Site specific NMR characterization of abeta-40 oligomers cross seeded by abeta-42 oligomers
por: Chang, Han-Wen, et al.
Publicado: (2022)

Highly specific and ultrasensitive plasma test detects Abeta(1–42) and Abeta(1–40) in Alzheimer’s disease
por: Thijssen, Elisabeth H., et al.
Publicado: (2021)

Mannan-Abeta(28 )conjugate prevents Abeta-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) mice
por: Petrushina, Irina, et al.
Publicado: (2008)

Potential sources of interference on Abeta immunoassays in biological samples
por: Vanderstichele, Hugo, et al.
Publicado: (2012)

Systemic Administration of Abeta mAb Reduces Retinal Deposition of Abeta and Activated Complement C3 in Age-Related Macular Degeneration Mouse Model
por: Catchpole, Ian, et al.
Publicado: (2013)

Comparing the efficacy and neuroinflammatory potential of three anti-abeta antibodies
por: Fuller, James P., et al.
Publicado: (2015)

Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer’s disease
por: Bayer, Thomas A., et al.
Publicado: (2014)

A Chemical Analog of Curcumin as an Improved Inhibitor of Amyloid Abeta Oligomerization
por: Orlando, Robert A., et al.
Publicado: (2012)

Acute Blast Injury Reduces Brain Abeta in Two Rodent Species
por: De Gasperi, Rita, et al.
Publicado: (2012)

Melatonin and Abeta, Macular Degeneration and Alzheimers Disease: Same Disease, Different Outcomes?
por: Vladan, Bajic, et al.
Publicado: (2012)

Abeta42-Induced Neurodegeneration via an Age-Dependent Autophagic-Lysosomal Injury in Drosophila
por: Ling, Daijun, et al.
Publicado: (2009)

Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota
por: Harach, T., et al.
Publicado: (2017)

Successful Nutritional Intervention for an Infant with Abetalipoproteinemia: A Novel Modular Formula (AbetaMF)
por: Ueda, Masako, et al.
Publicado: (2021)

Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study
por: Bermejo-Pareja, Felix, et al.
Publicado: (2010)

Abeta is prerequisite, but insufficient to cause tau phosphorylation in vivo: tau phosphorylation in APP mice by diabetes
por: Sato, Naoyuki
Publicado: (2013)

Erratum: Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota
por: Harach, T., et al.
Publicado: (2017)

Effects of Different Force Fields and Temperatures on the Structural Character of Abeta (12–28) Peptide in Aqueous Solution
por: Cao, Zanxia, et al.
Publicado: (2011)

Explore the Role of Abeta in Axonal Trafficking Deficits Induced by Alpha Synuclein in Parkinson Disease Mouse Model
por: Castro, Alfredo
Publicado: (2021)

Explore the Role of Abeta in Axonal Trafficking Deficits Induced by Alpha Synuclein in Parkinson Disease Mouse Model
por: Castro, Alfredo
Publicado: (2021)

A novel human tau knock-in mouse model reveals interaction of Abeta and human tau under progressing cerebral amyloidosis in 5xFAD mice
por: Barendrecht, Susan, et al.
Publicado: (2023)

Upstream stimulatory factors are involved in the P1 promoter directed transcription of the AbetaH-J-J locus
por: Finotti, Alessia, et al.
Publicado: (2008)

In vivo modification of Abeta plaque toxicity as a novel neuroprotective lithium-mediated therapy for Alzheimer’s disease pathology
por: Trujillo-Estrada, Laura, et al.
Publicado: (2013)

Design, Synthesis, and Validation of a Novel [(11)C]Promethazine PET Probe for Imaging Abeta Using Autoradiography
por: Whitmore, Clayton A., et al.
Publicado: (2021)

Kihi-to, a herbal traditional medicine, improves Abeta(25–35)-induced memory impairment and losses of neurites and synapses
por: Tohda, Chihiro, et al.
Publicado: (2008)

Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic mice
por: Spencer, Brian, et al.
Publicado: (2008)

Extracellular and intraneuronal HMW-AbetaOs represent a molecular basis of memory loss in Alzheimer's disease model mouse
por: Takamura, Ayumi, et al.
Publicado: (2011)

Immunohistochemical Evidence from APP-Transgenic Mice for Glutaminyl Cyclase as Drug Target to Diminish pE-Abeta Formation
por: Hartlage-Rübsamen, Maike, et al.
Publicado: (2018)

Dynamic changes of autophagic flux induced by Abeta in the brain of postmortem Alzheimer’s disease patients, animal models and cell models
por: Long, Zhimin, et al.
Publicado: (2020)

Semax, a Synthetic Regulatory Peptide, Affects Copper-Induced Abeta Aggregation and Amyloid Formation in Artificial Membrane Models
por: Sciacca, Michele F.M., et al.
Publicado: (2022)

Destabilization potential of beta sheet breaker peptides on Abeta fibril structure: an insight from molecular dynamics simulation study
por: Jani, Vinod, et al.
Publicado: (2021)

Involvement of LPA(1 )receptor signaling in the reorganization of spinal input through Abeta-fibers in mice with partial sciatic nerve injury
por: Xie, Weijiao, et al.
Publicado: (2008)

Abeta(1-42) Enhances Neuronal Excitability in the CA1 via NR2B Subunit-Containing NMDA Receptors
por: Varga, Edina, et al.
Publicado: (2014)

Single Chain Variable Fragment Against Aβ Expressed in Baculovirus Inhibits Abeta Fibril Elongation and Promotes its Disaggregation
por: Zhang, Ying, et al.
Publicado: (2015)

Synergistic Effect on Neurodegeneration by N-Truncated Aβ(4−42) and Pyroglutamate Aβ(3−42) in a Mouse Model of Alzheimer's Disease
por: Lopez-Noguerola, Jose S., et al.
Publicado: (2018)

MicroRNAs 99b-5p/100-5p Regulated by Endoplasmic Reticulum Stress are Involved in Abeta-Induced Pathologies
por: Ye, Xiaoyang, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qkqtnfvs86jr1hr9ufv1diq260